Parasitic infections.
D000563:Amebicides / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D001196:Ascariasis; D001557:Benzenesulfonates / Q000627:therapeutic use; D002590:Cestode Infections; D004443:Echinococcosis; D004749:Entamoebiasis; D006725:Hookworm Infections; D006801:Humans; D008288:Malaria; D009534:Niclosamide / Q000627:therapeutic use; D009560:Niridazole / Q000627:therapeutic use; D010123:Oxyuriasis; D010272:Parasitic Diseases; D010303:Paromomycin / Q000627:therapeutic use; D011716:Pyrantel Pamoate / Q000627:therapeutic use; D012552:Schistosomiasis; D013322:Strongyloidiasis; D013644:Tartrates / Q000627:therapeutic use; D013750:Tetrachloroethylene / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D013827:Thiabendazole / Q000627:therapeutic use; D014120:Toxocariasis; D014235:Trichinellosis
D000563:Amebicides; D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D001557:Benzenesulfonates; D013644:Tartrates; D010303:Paromomycin; D011716:Pyrantel Pamoate; D009534:Niclosamide; D013752:Tetracycline; D009560:Niridazole; D013827:Thiabendazole; D013750:Tetrachloroethylene